| Old Articles: <Older 3171-3180 Newer> |
|---|
 |
Pharmaceutical Executive
October 1, 2006
Robert Schneider |
Medical Education: Gauging Success Pharma is investing in CME. Is the money being well spent?   |
Pharmaceutical Executive
October 1, 2006
Laurence G. Poli |
Back Page: Pharma's Mega-Brands Pharma's biggest blockbusters bring in more revenue than many Fortune 500 companies. So why not manage them that way? |
The Motley Fool
October 9, 2006
Brian Lawler |
Much-Needed Publicity for Millennium Millennium Pharmaceuticals' cancer-fighting drug Velcade is set to gain exposure for a new treatment. Investors, take note. |
The Motley Fool
October 9, 2006
Brian Lawler |
New Drug for New River An approvable letter from the FDA sends shares of New River Pharmaceuticals up. |
The Motley Fool
October 6, 2006
Brian Lawler |
No Bloodbath at Immucor The company appears right on track for double-digit revenue growth. Investors, it is worth watching to see how Immucor copes with the retirement of its CEO last month, but most likely everything should proceed as normal. |
The Motley Fool
October 5, 2006
Brian Lawler |
Elan Extends Tysabri's Reach The MS-fighting drug gains approval in Canada. Next month, when Biogen and Elan report third-quarter results, investors will get a preliminary indication of how these sales of Tysabri are ramping up. |
The Motley Fool
October 4, 2006
Brian Lawler |
Unwelcome Guests at ImClone ImClone's board of directors votes against Carl Icahn's proposed removal of six company directors. Short-term shareholders that are able to cash out with Icahn, will possibly have a nice gain to take home. |
The Motley Fool
October 3, 2006
Brian Gorman |
Britain's Psychiatric Stir-Up The U.S. government may be forced to follow Great Britain's example regarding drug reimbursements, given recent developments in Medicare. What will this mean for Big Pharma? |
BusinessWeek
October 9, 2006 |
Boston Scientific's Double Bypass First, quality problems with its defibrillators. Now, doubts about the safety of Boston Scientific's coated stents |
BusinessWeek
October 9, 2006
Joseph Weber |
UnitedHealth vs. HCA: It's Ugly UnitedHealth's contract dispute is leaving patients and docs out in the cold. |
| <Older 3171-3180 Newer> Return to current articles. |
